Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-08-03DOI: 10.1002/cncy.22892
Kaitlyn R Muscarella, Paul T Eberts, Laura D Craig-Owens, Elizabeth Kean Groark, Dustin R Osborne, Teresa Osborne, Gregg Tracy, Cristopher D Stephens, Laurentia M Nodit
{"title":"Mucinous-appearing contamination of serous effusions by sodium carboxymethyl cellulose from suction canister lids.","authors":"Kaitlyn R Muscarella, Paul T Eberts, Laura D Craig-Owens, Elizabeth Kean Groark, Dustin R Osborne, Teresa Osborne, Gregg Tracy, Cristopher D Stephens, Laurentia M Nodit","doi":"10.1002/cncy.22892","DOIUrl":"10.1002/cncy.22892","url":null,"abstract":"","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22892"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-11-05DOI: 10.1002/cncy.22916
Frances Xiuyan Feng, George G Birdsong, Jane Wei, Melad N Dababneh, Michelle D Reid, Michael Hoskins, Qun Wang
{"title":"Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.","authors":"Frances Xiuyan Feng, George G Birdsong, Jane Wei, Melad N Dababneh, Michelle D Reid, Michael Hoskins, Qun Wang","doi":"10.1002/cncy.22916","DOIUrl":"10.1002/cncy.22916","url":null,"abstract":"<p><strong>Background: </strong>In 2019, the American Society for Colposcopy and Cervical Pathology introduced fundamental shifts toward \"risk-based\" guidelines, with human papillomavirus (HPV) genotyping as a principal test for investigating squamous intraepithelial lesions. This study aims to provide practice-based evidence and supplement the updated guidelines by investigating HPV demographic distribution and uncovering the pathological features of high-grade squamous intraepithelial lesions (HSILs) caused by high-risk HPV (hrHPV) subtypes.</p><p><strong>Methods: </strong>Patients who underwent Papanicolaou screening and HPV testing in two hospital systems over the course of 4 years were recruited. The cytology results were categorized on the basis of the 2014 Bethesda classification. DNA sequences of 14 types of hrHPV were detected by Aptima test. The histological features of HSILs caused by different subtypes were compared between biopsies and excisions.</p><p><strong>Results: </strong>A total of 63,709 cases were included. The HPV prevalence was 14.70%, predominantly in the 30 to 39-year-old age group, with slightly higher rates observed in African Americans. There was no significant racial distribution difference between HPV 16/18/45 and other types. HPV 16/18/45 infection was directly correlated with the severity of abnormal cytology, although the other subtypes were the major causes of cytological abnormalities. The trend for HPV prevalence was consistent across calendar years, and was associated with 8.77% negative for intraepithelial lesion or malignancy, 30.46% atypical squamous cell of undetermined significance, 64.62% low-grade squamous intraepithelial lesion, 66.75% atypical squamous cell-cannot exclude a high-grade squamous intraepithelial lesion, and 91.80% HSIL. Furthermore, 29.09% of HSILs associated with other subtypes were not detectable on subsequent resections.</p><p><strong>Conclusions: </strong>Given the HPV demographic distribution and the histological features of HSILs caused by different subtypes, cotesting with reflex HPV genotyping in specific populations, or expanding the subtypes in the primary HPV screening test, should be considered.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22916"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-10-16DOI: 10.1002/cncy.22911
Maren Y Fuller, Sujan Shrestha, Swikrity U Baskota
{"title":"International perspective on pediatric cytology.","authors":"Maren Y Fuller, Sujan Shrestha, Swikrity U Baskota","doi":"10.1002/cncy.22911","DOIUrl":"10.1002/cncy.22911","url":null,"abstract":"","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22911"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-12-10DOI: 10.1002/cncy.22923
Tuba Dilay Kökenek Ünal, Ayşegül Aksoy Altınboğa
{"title":"A pilot study of the value of micronucleus count in urinary cytology samples in the follow-up of patients with urothelial carcinoma: Implications for diagnosis and prognosis.","authors":"Tuba Dilay Kökenek Ünal, Ayşegül Aksoy Altınboğa","doi":"10.1002/cncy.22923","DOIUrl":"10.1002/cncy.22923","url":null,"abstract":"<p><strong>Background: </strong>Nuclear protrusions such as micronuclei (MNs) and nuclear budding (NB) are morphological findings of chromosomal instability and indicators of genotoxic damage. They are increased in malignancies, and their high frequency may be used in the diagnosis of cancers and the follow-up of patients. Urothelial carcinomas are common tumors that cause morbidity and mortality, and cytology is a commonly used method for the monitoring and screening of urothelial carcinoma. Although the cytological evaluation of urinary samples is mainly based on nuclear features, there is limited research focusing on MN frequency in urinary cytology. This study aimed to investigate MN and NB counts in various diagnostic categories of urinary samples.</p><p><strong>Methods: </strong>This study included 117 urinary cytology samples categorized according to The Paris System for Reporting of Urinary Cytology. Two observers, blinded to the diagnosis, counted the frequency of MNs and NB per 1000 cells on May-Grünwald-Giemsa- and Papanicolaou-stained slides.</p><p><strong>Results: </strong>MN and NB counts significantly differed among the groups (p < .001 for each) with a large effect (Ɛ<sup>2</sup> = 0.509). MN and NB counts were significantly higher in cases with high-grade urothelial carcinoma (HGUC) than in control cases and in cases that were negative for HGUC or with atypical urothelial cells (p < .001 for each). Any MN count greater than 2.5 per 1000 cells indicated HGUC with a 55% sensitivity and 92.4% specificity.</p><p><strong>Conclusions: </strong>Because increased MN and NB frequencies are closely associated with an increased risk of malignancy, these could be integrated into The Paris System for Reporting of Urinary Cytology.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22923"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Counseling gap may worsen endometrial cancer disparities in Black women: A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counseling.","authors":"Bryn Nelson, William Faquin","doi":"10.1002/cncy.22928","DOIUrl":"https://doi.org/10.1002/cncy.22928","url":null,"abstract":"","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":"133 1","pages":"e22928"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142920747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-10-08DOI: 10.1002/cncy.22910
Joshua J X Li, Hiu Yu Cheng, Conrad H C Lee, Joanna K M Ng, Julia Y Tsang, Gary M Tse
{"title":"Single-cell multiplex immunocytochemistry in cell block preparations of metastatic breast cancer confirms sensitivity of GATA-binding protein 3 over gross cystic disease fluid protein 15 and mammaglobin.","authors":"Joshua J X Li, Hiu Yu Cheng, Conrad H C Lee, Joanna K M Ng, Julia Y Tsang, Gary M Tse","doi":"10.1002/cncy.22910","DOIUrl":"10.1002/cncy.22910","url":null,"abstract":"<p><strong>Background: </strong>Metastatic breast cancers are frequently encountered in cytology and require immunocytochemistry (ICC). In this study, traditional and multiplex ICC (mICC) for GATA-binding protein 3 (GATA3), gross cystic disease fluid protein 15 (GCDFP15), and mammaglobin (MMG) were performed with the aim of validating mICC in cell blocks, with further single-cell expression pattern analysis to identify the single markers and combinations of markers most sensitive in subtypes of breast cancer.</p><p><strong>Methods: </strong>GATA3, GCDFP15, and MMG were paired with OptiView 3,3'-diaminobenzidine and Ventana DISCOVERY Purple and Blue, respectively, with cyclical and serial staining. Bright-field imaging was performed with the Mantra 2 system and analyzed with the inForm Tissue Finder (Akoya Biosciences). Cell detection and phenotyping were further confirmed by two pathologists.</p><p><strong>Results: </strong>In the 36 cases studied, traditional ICC and mICC demonstrated good concordance (kappa coefficient, >0.5; p < .01) at three cutoffs (1%, 5%, and 50%), except for GATA3 at the 1% cutoff. Single-marker positivity outnumbered double-marker positivity and the exceedingly rare triple-marker positivity (<3%). GATA3 was the leading single marker-positive phenotype in all breast cancer subtypes, except for MMG in estrogen receptor-positive, progesterone receptor-positive, and human epidermal growth factor receptor 2-positive (ER+/PR+/HER2+) breast cancers. Limited to two markers, GATA3/MMG included the greatest number of tumor cells for luminal breast cancers (ER+/PR+/HER2+, 60.6%; ER+/PR+/HER2+, 31.4%), whereas HER2-overexpressed breast cancers (27.4%) and triple-negative breast cancers (26.4%) favored the combination of GATA3/GCDFP15.</p><p><strong>Conclusions: </strong>For a single marker, GATA3 displayed the highest sensitivity. The addition of MMG for hormone receptor-positive breast cancers and GCDFP15 for hormone receptor-negative breast cancers further increased sensitivity. The low proportion of multimarker-positive cells suggested that the coexpression observed with traditional ICC is attributable to intratumoral heterogeneity, not genuine coexpression.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22910"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J Bryan Iorgulescu, Richard Kenneth Yang, Sinchita Roy Chowdhuri, Gloria Hopkins Sura
{"title":"Same-day molecular testing for targetable mutations in solid tumor cytopathology-The next frontier of the rapid on-site evaluation.","authors":"J Bryan Iorgulescu, Richard Kenneth Yang, Sinchita Roy Chowdhuri, Gloria Hopkins Sura","doi":"10.1002/cncy.22930","DOIUrl":"https://doi.org/10.1002/cncy.22930","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to assess the feasibility of implementing the Idylla system, an ultra-rapid, cartridge-based assay, as an extension of rapid on-site evaluation (ROSE) in cytology. The authors conducted a pilot validation study on specimens from non-small cell lung carcinoma, thyroid carcinoma, and melanoma, evaluating four assays designed to detect alterations in KRAS, EGFR, BRAF, gene fusions, and expression imbalances in ALK, ROS1, RET, NTRK1/2/3, and MET exon 14 skipping transcripts. They investigated the feasibility of providing accurate biomarker molecular testing results in a cytopathology laboratory within hours of specimen collection.</p><p><strong>Methods: </strong>The authors evaluated the performance characteristics and turn-around-time of the Idylla system by testing a total of 144 cartridge assays across various specimen types, including fine-needle aspirate smears, formalin-fixed paraffin-embedded (FFPE) cell blocks, small tissue biopsy FFPE blocks, and control cell line FFPE scrolls.</p><p><strong>Results: </strong>The average time from specimen input to results output was 2-3 hours. Accuracy across the four cartridge types was: KRAS assay: 100%, EGFR assay: 94%, BRAF assay: 100%, and GeneFusion assay: 94%. Analytical sensitivity ranged from 1% to 5% variant allele frequency for all assays. Inter-assay precision and analytical specificity were both 100%.</p><p><strong>Conclusion: </strong>Using the Idylla system, actionable genetic alterations can be reliably detected within 2-3 hours from cytology and small biopsy samples with minimal input requirements. The findings of this study demonstrate the feasibility of incorporating same-day molecular testing as part of ROSE procedures in the cytopathology laboratory, ultimately shortening the time from procedure to personalized treatment for cancer patients.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":"133 1","pages":"e22930"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142920749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Thin-layer cervical sample evaluation: Conventional light microscopy versus digital whole-slide imaging.","authors":"Jessica Viti, Chiara Di Stefano, Serena Giunti, Giampaolo Pompeo, Paola Pezzati, Alessandro Terreni, Cristina Sani","doi":"10.1002/cncy.22921","DOIUrl":"10.1002/cncy.22921","url":null,"abstract":"<p><strong>Background: </strong>Whole-slide imaging (WSI) has been adopted in many fields of pathology for education, quality assurance, and remote diagnostics. In 2021, the College of American Pathologists (CAP) updated guidelines to support pathology laboratories regarding the WSI systems validation process. However, the majority of published literature refers to histopathology rather than cytology. The aim of this study was to compare conventional light microscopy (CLM) and WSI in thin-layer cervical samples evaluation according to CAP guideline.</p><p><strong>Methods: </strong>A sample set of 64 thin-layer cervical specimens from women 25-64 years old who participated in cervical cancer screening programs in Tuscany was distributed among five cytologists at Institute for Cancer Research, Prevention and Clinical Network (Florence, Italy) for CLM analysis. After 2 weeks, the corresponding 64 digitally scanned slides were available at several magnifications for WSI evaluation.</p><p><strong>Results: </strong>Substantial/near perfect agreement between CLM and WSI evaluation (0.77 ≥ κ ≥1) was observed for the negative for intraepithelial lesion or malignancy (NILM) class with concordance rates from 83.3% to 100%.Variability in concordance was observed among all the cytologists: 50%-85.7% for low-grade squamous intraepithelial lesion (LSIL), 47.1%-100% for high-grade squamous intraepithelial lesion (HSIL), 50%-100% for atypical glandular cells (AGCs) favors adenocarcinoma (ADK) with moderate/near perfect agreement (0.47 ≥ κ ≥1). Concordance and agreement rates were also variable within the \"borderline\" cytological categories of atypical squamous cells of undetermined significance (ASC-US), atypical squamous cells cannot exclude an HSIL (ASC-H), and AGCs with lower or not computable kappa for some readers. The overall intralaboratory concordance between CLM and WSI was 92.9% with a near perfect agreement (κ = 0.84) for NILM. Substantial agreement (κ ≥0.65) was assessed for LSIL, HSIL/squamous cell carcinoma, AGCs, and ADK categories whereas the agreement was lower (κ ≤0.39) for ASC-US and ASC-H.</p><p><strong>Conclusions: </strong>This study showed an overall substantial/near perfect agreement between CLM and WSI for all the cytological categories except the \"borderline\" ASC-US and ASC-H. Further progress in cytology WSI systems are needed before introducing it in routine diagnostics.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22921"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"State pathology societies-valuable resources for trainees.","authors":"Myles R McCrary, Carmen Gomez-Fernandez","doi":"10.1002/cncy.22926","DOIUrl":"10.1002/cncy.22926","url":null,"abstract":"","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":"133 1","pages":"e22926"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142920750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer CytopathologyPub Date : 2025-01-01Epub Date: 2024-10-15DOI: 10.1002/cncy.22914
Kara Tanaka, Neslihan Kayraklioglu, Emily Chan, Chien-Kuang C Ding, Poonam Vohra
{"title":"Utility of The Paris System for Reporting Urinary Cytology in patients with HPV-positive urinary tract carcinoma.","authors":"Kara Tanaka, Neslihan Kayraklioglu, Emily Chan, Chien-Kuang C Ding, Poonam Vohra","doi":"10.1002/cncy.22914","DOIUrl":"10.1002/cncy.22914","url":null,"abstract":"<p><strong>Background: </strong>Human papillomavirus (HPV)-positive urinary tract carcinomas (UTCas) have distinct morphology and molecular features with potential treatment implications. Cytomorphologic analysis of these tumors on urine cytology specimens has not yet been reported. The authors evaluated the cytomorphologic findings of HPV-positive UTCa on urine cytology using The Paris System for Reporting Urinary Cytology (TPS) criteria.</p><p><strong>Methods: </strong>HPV-positive cases were identified by a retrospective review of surgical specimens that had UTCa confirmed by HPV in situ hybridization. Cases that had concurrent urine cytology were reviewed using TPS. Cytomorphologic features of high-grade urothelial carcinoma (HGUC) were evaluated as well as the presence of atypical squamous cells (ASCs) and basaloid features.</p><p><strong>Results: </strong>Sixteen cytology specimens from eight patients with HPV-positive UTCa were included. On original diagnosis, none of the cytology specimens were suggested to be HPV-associated. TPS diagnostic criteria identified eight cases with at least atypical findings, including five HGUC cases, one case that was suspicious for HGUC, and two atypical urothelial cases. Common cytomorphologic features included basaloid clusters (six of eight cases; 75%) and ASCs (four of eight cases; 50%) that matched the corresponding surgical specimens. Most cases exhibited urothelial cell hyperchromasia (seven of eight cases; 88%), and hypochromasia was a frequently observed variant (four of eight cases; 50%), either alone or in addition to hyperchromasia.</p><p><strong>Conclusions: </strong>HPV-positive UTCa can be identified reliably as HGUC by using TPS criteria; however, these cases may not be recognized as HPV-associated. The presence of basaloid cells or ASCs can help suggest screening for HPV in urine specimens. Larger scale studies are warranted to validate cytomorphologic differences and determine the impact of HPV infection on clinical outcomes for patients with UTCa.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":"e22914"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}